43 results
Page 2 of 3
8-K
EX-99.1
r2dt2i4e1
10 Aug 21
Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:05pm
424B5
gpt0v1xwxxvi7q2zx
8 Apr 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
pwjj6e1o zi2ewen1fcu
30 Mar 21
Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
5:05pm
8-K
EX-99.1
z6c0z04fnam 3jo
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am
424B5
d7cmbe3buqfm
15 Apr 20
Prospectus supplement for primary offering
4:16pm
424B5
pd8la rpo
14 Apr 20
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.1
aw846zrvlun2q8kc75
12 Nov 19
Crinetics Pharmaceuticals Reports Third Quarter 2019
4:01pm
S-3/A
r8t9rh
19 Aug 19
Shelf registration (amended)
4:17pm
S-3
sxvg m7unv0wy3czj
13 Aug 19
Shelf registration
4:36pm
8-K
EX-99.1
smzmw klqc
13 Aug 19
Crinetics Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
4:11pm
8-K
EX-99.1
yhad39cc011hb41vja
16 Jul 19
Crinetics Pharmaceuticals Appoints Stephanie Okey to Board of Directors
9:00am
DEF 14A
8ckctijq4m tvg
29 Apr 19
Definitive proxy
12:00am
10-K
itpfim
13 Mar 19
Annual report
4:06pm
8-K
EX-99.1
beoxg6u uhgehp7q82p
1 Oct 18
Regulation FD Disclosure
4:01pm
424B4
aokugxcobnn0zb8
18 Jul 18
Prospectus supplement with pricing info
5:27pm
S-1/A
e1prc pbenk3gz575i
9 Jul 18
IPO registration (amended)
6:10am